Media – NeuroScientific Biopharmaceuticals

In The Media

NeuroScientific Biopharmaceuticals
and EmtinB in the media

As EmtinB continues to demonstrate positive results and nears clinical trials,
NeuroScientific Biopharmaceuticals has been gaining media coverage for our innovative approach as well as sharemarket performance.

September, 2022

Investor Update from NSB Chairman Paul Rennie

September, 2022

NeuroScientific Biopharmaceuticals Investor Update Webinar

December, 2021

NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”

November, 2021

Broker Briefing Webinar with Dr Alexandra Andrews

September, 2021

Investor Webinar Presentation ShareCafe Small Cap “Hidden Gems” Webinar

August, 2021

90 Second video interview with NSB Chairman, Mr Paul Rennie

July, 2021

NeuroScientific’s Director of Operations, Dr Alexandra Heaton Interview with Gareth Quinn of Republic PR

June, 2021

NeuroScientific Biopharmaceuticals – Gold Coast Investment Showcase 2021

October, 2019

NeuroScientific Biopharmaceuticals taking a different approach to treat Alzheimer’s Disease

July, 2019

NeuroScientific Biopharmaceuticals shares soar on nerve regeneration results

June, 2019

Neuroscientific Biopharmaceuticals – 121 Tech Investment Hong Kong 2019 Spring

December, 2018

Matt Liddelow, NeuroScientific Biopharmaceuticals – 121 Tech Investment Singapore 2018

December, 2018

NeuroScientific Biopharmaceuticals – 121 Tech Investment Singapore

November, 2018

TechKnow Roadshow Q&A: Brian Leedman

June, 2018

AFR: NeuroScientific targets Alzheimer’s cure

April, 2018

Interview with NeuroScientific Biopharmaceuticals CEO and MD Matt Liddelow

NeuroScientific Biopharmaceuticals and EmtinB in the media

Subscribe for important NeuroScientific announcements and updates

NeuroScientific Biopharmaceuticals
and EmtinB in the media